{
  "input": {
    "mode": "execute_actions",
    "query": {
      "entity": "Hereditary haemorrhagic telangiectasia",
      "relation": "contraindication"
    },
    "items": [
      {
        "hypothesis_id": "H1",
        "graph_actions": [
          {
            "type": "stress_test_safety",
            "topic": "出血风险",
            "expectation": "评估Aspirin对HHT患者的具体影响，明确禁忌原因",
            "assignee": "Skeptic"
          },
          {
            "type": "stress_test_safety",
            "topic": "出血风险",
            "expectation": "评估Ibuprofen对HHT患者的影响，明确禁忌原因",
            "assignee": "Skeptic"
          },
          {
            "type": "stress_test_safety",
            "topic": "出血风险",
            "expectation": "评估Warfarin对HHT患者的影响，重申禁忌指示",
            "assignee": "Skeptic"
          },
          {
            "type": "stress_test_safety",
            "topic": "出血风险",
            "expectation": "评估Clopidogrel对HHT患者的影响",
            "assignee": "Skeptic"
          },
          {
            "type": "stress_test_safety",
            "topic": "出血风险",
            "expectation": "评估Rivaroxaban对HHT患者的潜在影响",
            "assignee": "Skeptic"
          },
          {
            "type": "stress_test_safety",
            "topic": "出血风险",
            "expectation": "评估Heparin对HHT患者的影响",
            "assignee": "Skeptic"
          },
          {
            "type": "stress_test_safety",
            "topic": "出血风险",
            "expectation": "评估Dipyridamole对HHT患者的影响",
            "assignee": "Skeptic"
          },
          {
            "type": "stress_test_safety",
            "topic": "出血风险",
            "expectation": "评估Thrombin inhibitors对HHT患者的影响",
            "assignee": "Skeptic"
          },
          {
            "type": "stress_test_safety",
            "topic": "出血风险",
            "expectation": "评估NSAIDs对HHT患者的影响",
            "assignee": "Skeptic"
          },
          {
            "type": "stress_test_safety",
            "topic": "出血风险",
            "expectation": "评估Beta-blockers对HHT患者的潜在影响",
            "assignee": "Skeptic"
          },
          {
            "type": "stress_test_safety",
            "topic": "出血风险",
            "expectation": "评估Anticoagulants对HHT患者的影响",
            "assignee": "Skeptic"
          },
          {
            "type": "stress_test_safety",
            "topic": "出血风险",
            "expectation": "评估Antithrombotic agents对HHT患者的影响",
            "assignee": "Skeptic"
          }
        ]
      }
    ],
    "tegraph_snapshot": {
      "nodes": [
        {
          "id": "drug_aspirin",
          "type": "Drug",
          "label": "Aspirin",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_ibuprofen",
          "type": "Drug",
          "label": "Ibuprofen",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_warfarin",
          "type": "Drug",
          "label": "Warfarin",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_clopidogrel",
          "type": "Drug",
          "label": "Clopidogrel",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_rivaroxaban",
          "type": "Drug",
          "label": "Rivaroxaban",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_heparin",
          "type": "Drug",
          "label": "Heparin",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_dipyridamole",
          "type": "Drug",
          "label": "Dipyridamole",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_thrombin_inhibitors",
          "type": "Drug",
          "label": "Thrombin inhibitors",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_nonsteroidal_anti_inflammatory_drugs",
          "type": "Drug",
          "label": "Nonsteroidal anti-inflammatory drugs",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_beta_blockers",
          "type": "Drug",
          "label": "Beta-blockers",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_anticoagulants",
          "type": "Drug",
          "label": "Anticoagulants",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_antithrombotic_agents",
          "type": "Drug",
          "label": "Antithrombotic agents",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "disease_hereditary_haemorrhagic_telangiectasia",
          "type": "Disease",
          "label": "Hereditary haemorrhagic telangiectasia",
          "attrs": {
            "agent": "Proponent"
          }
        }
      ],
      "edges": [
        {
          "source": "drug_aspirin",
          "target": "disease_hereditary_haemorrhagic_telangiectasia",
          "relation": "contraindication",
          "weight": 0.9,
          "agent": "Proponent",
          "rationale": "Aspirin已知影响出血倾向"
        },
        {
          "source": "drug_ibuprofen",
          "target": "disease_hereditary_haemorrhagic_telangiectasia",
          "relation": "contraindication",
          "weight": 0.85,
          "agent": "Proponent",
          "rationale": "Ibuprofen可能加重出血"
        },
        {
          "source": "drug_warfarin",
          "target": "disease_hereditary_haemorrhagic_telangiectasia",
          "relation": "contraindication",
          "weight": 0.95,
          "agent": "Proponent",
          "rationale": "Warfarin严重影响凝血"
        },
        {
          "source": "drug_clopidogrel",
          "target": "disease_hereditary_haemorrhagic_telangiectasia",
          "relation": "contraindication",
          "weight": 0.85,
          "agent": "Proponent",
          "rationale": "Clopidogrel增加出血风险"
        },
        {
          "source": "drug_rivaroxaban",
          "target": "disease_hereditary_haemorrhagic_telangiectasia",
          "relation": "contraindication",
          "weight": 0.75,
          "agent": "Proponent",
          "rationale": "Rivaroxaban影响血液凝固"
        },
        {
          "source": "drug_heparin",
          "target": "disease_hereditary_haemorrhagic_telangiectasia",
          "relation": "contraindication",
          "weight": 0.7,
          "agent": "Proponent",
          "rationale": "Heparin增加出血可能性"
        },
        {
          "source": "drug_dipyridamole",
          "target": "disease_hereditary_haemorrhagic_telangiectasia",
          "relation": "contraindication",
          "weight": 0.6,
          "agent": "Proponent",
          "rationale": "Dipyridamole可能影响凝血"
        },
        {
          "source": "drug_thrombin_inhibitors",
          "target": "disease_hereditary_haemorrhagic_telangiectasia",
          "relation": "contraindication",
          "weight": 0.65,
          "agent": "Proponent",
          "rationale": "Thrombin inhibitors对出血有影响"
        },
        {
          "source": "drug_nonsteroidal_anti_inflammatory_drugs",
          "target": "disease_hereditary_haemorrhagic_telangiectasia",
          "relation": "contraindication",
          "weight": 0.6,
          "agent": "Proponent",
          "rationale": "NSAIDs已知影响出血风险"
        },
        {
          "source": "drug_beta_blockers",
          "target": "disease_hereditary_haemorrhagic_telangiectasia",
          "relation": "contraindication",
          "weight": 0.55,
          "agent": "Proponent",
          "rationale": "Beta-blockers在某些情况下可能影响出血"
        },
        {
          "source": "drug_anticoagulants",
          "target": "disease_hereditary_haemorrhagic_telangiectasia",
          "relation": "contraindication",
          "weight": 0.9,
          "agent": "Proponent",
          "rationale": "Anticoagulants对出血有直接影响"
        },
        {
          "source": "drug_antithrombotic_agents",
          "target": "disease_hereditary_haemorrhagic_telangiectasia",
          "relation": "contraindication",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "Antithrombotic agents增加出血风险"
        }
      ],
      "round_index": 4
    },
    "constraints": {
      "max_new_nodes": 50,
      "max_new_edges": 64,
      "batched": true
    },
    "ablation_config": {
      "enable_debate": true,
      "enable_skeptic": true,
      "enable_pi_interrupts": true,
      "enable_textual_feedback": true,
      "enable_heuristic_transfer": true,
      "enable_seed_regen": true,
      "weights": {
        "path_disjointness": 1.0
      },
      "mode": "graph"
    }
  },
  "output": {
    "graph_updates_per_hypothesis": []
  }
}